Rivaroxaban als effektive Therapieoption der Livedovaskulopathie

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

Abstract

The livedoid vasculopathy is a rare disease caused by thromboembolic occlusion of small and medium vessels in the superficial dermal plexus. Immunosuppressive treatment was often ineffective and resulted in a refractory disease cause. The efficiency of anticoagulants in the treatment of the disease was described a couple of years ago. Here, we report successful treatment with rivaroxaban and fast achievement of remission in a 30-year-old patient with livedoid vasculopathy.

Details

OriginalspracheDeutsch
Seiten (von - bis)199-201
Seitenumfang3
FachzeitschriftAktuelle Dermatologie
Jahrgang43
Ausgabenummer5
PublikationsstatusVeröffentlicht - 1 Mai 2017
Peer-Review-StatusJa

Externe IDs

ORCID /0000-0002-8217-6872/work/152545006
ORCID /0000-0002-2164-4644/work/152545843
ORCID /0000-0002-4330-1861/work/152544350

Schlagworte

ASJC Scopus Sachgebiete